A significant shift in our drug policy has taken place, as the government permit the use of psilocybin mushrooms for therapeutic purposes. Previously, these substances were severely restricted, but a increasing body of evidence suggests they potentially offer benefits for emotional illnesses like anxiety. The new policy represents a major step towa